Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder

British Journal of Cancer

Volumn 79, Issue 5-6, 1999, Pages 770-779

  Milella, M ^a   Jacobelli, J ^a   Cavallo, F ^b   Guarini, A ^c   Velotti, F ^d   Frati, L ^a   Foa R ^c   Forni, G ^b   Santoni, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF TUSCIA   (Italy)

Author keywords

Gene therapy; Human; Immunotherapy; Interleukin 2; Transitional bladder cancer

Indexed keywords

INTERLEUKIN 2; MESSENGER RNA; VIRUS VECTOR;

ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; GENE TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

ANIMALS; CARCINOMA, TRANSITIONAL CELL; CELL ADHESION MOLECULES; FEMALE; GENE THERAPY; GENETIC VECTORS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-2; MICE; MICE, NUDE; RETROVIRIDAE; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0033002670     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690124     Document Type: Article

References (44)

1. Alosco T, Croy BA, Gansbacher B, Wang HQ, Rao U and Bankert R (1993) Anti-tumour response independent of functional B and T lymphocytes induced by the local and sustained release of interleukin-2 by the tumour cell. Cancer Immunol Immunother 36: 364-372
2. Bass C, Cabrera G, Elgavish A, Robert B, Siegal GP, Anderson SC, Maneval DC and Curiel DT (1995) Recombinant adenovirus-mediated gene transfer to genitourinary epithelium in vitro and in vivo. Cancer Gene Ther 2: 97-104
3. Cavallo F, Giovarelli M, Gulino A, Vacca A, Stoppacciaro A, Modesti A and Forni G (1992) Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to non-immunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J Immunol 149; 3627-3635
4. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
5. Cignetti A, Guarini A, Carbone A, Forni M, Cronin K, Forni G, Gansbacher B and Foà R (1994)Transduction of the IL-2 gene into human acute leukemia cells: induction of tumor rejection without modifying cell proliferation and IL-2 expression. J Natl Cancer Inst 86: 785-791
6. Colombo MP, Modesti A, Parmiani G and Forni G (1992) Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res 52: 4853-4857
7. Connor J, Bannerji R, Saito S, Heston W, Fair W and Gilboa E (1993) Regression of bladder tumours in mice treated with IL-2 gene-modified tumour cells. J Exp Med 177: 1127-1134
8. Djeu JY, Liu JH, Wei S, Rui H, Pearson CA, Leonard WJ and Blanchard DK (1993) Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2. J Immunol 150: 960-70
9. Dranoff G and Mulligan RC (1995) Gene transfer as cancer therapy. Adv Immunol 58: 417-454
10. Dusty Miller A and Rosman GJ (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques 7: 980-986
11. Fearon ER, Pardoll DM, Itaya T, Golumbek P, Levitsky HI, Simons JW, Karasuyama H, Vogelstein B and Frost P (1990) Interleukin-2 production by tumour cells bypasses T helper function in the generation of an anti-tumour response. Cell 60: 397-403
12. Forni G, Cavallo GP, Giovarelli M, Benetton G, Jemma C, Barioglio MG, De Stefani A, Forni M, Santoni A, Modesti A, Cavallo G, Menzio P and Cortesina G (1988) Tumor immunotherapy by local injection of interleukin-2 and non-reactive lymphocytes. Experimental and clinical results. Prog Exp Tumor Res 32: 187-212
13. Gansbacher B, Zier K, Cronin K, Hantzopoulos PA, Bouchard B, Houghton A, Gilboa E and Golde D (1992) Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-γ in irradiated human mełanoma cells. Blood 80: 2817-2825
14. Gastl G, Finstad CL, Guarini A, Golde D, Bosl G, Bander NH, Gilboa E and Gansbacher B (1992) Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells. Cancer Res 52: 6229-6236
15. Girard D, Gosselin J, Heitz D, Paquin R and Beaulieu AD (1995) Effects of interleukin-2 on gene expression in human neutrophils, Blood 86: 1170-1176
16. Guarini A, Gansbacher B, Cronin K, Fierro MT and Foà R (1995) IL-2 gene-transduced human HLA-A2 mełanoma cells can generate a specific anti-tumour cytotoxic T-lymphocyte response. Cytokines Mol Ther 1: 57-64
17. Guarini A, Riera L, Reato G, Carbone A, Cignetti A, Gillio Tos A, Lanfrancone L, Melani C, Paul RW, Forni G and Foà R (1996) Human łung carcinoma cells engineered to release IL-2, IL-7, GM-CSF, and TNF-α: growth in nu/nu mice and modulation of TGF-β 1 production. Int J Oncol 8: 765-772
18. Guarini A, Riera L, Cignetti A, Montacchini L, Massaia M and Foà R (1997) Transfer of the interleukin-2 gene into human cancer cells induces specific anti-tumour recognition and restores the expression of CD3/T-cell receptor associated signal transduction molecules. Blood 89: 212-218
19. Hara I, Nguyen H, Takechi Y, Gansbacher B, Chapman PB and Houghton AN (1995) Rejection of mouse melanoma elicited by local secretion of interleukin-2: implicating macrophages without T celts or natural killer cells in tumor rejection. Int J Cancer 61: 253-260
20. Hathorn RW, Tso CL, Kaboo R, Pang S, Figlin R, Sawyers C, deKernion JB and Belldegrun A (1994) In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-α gene transfer. Cancer 74: 1904-1911
21. Hawkyard SJ, Jackson AM, Prescott KJ and Chisholm GD (1993) The effect of recombinant cytokines on bladder cancer cells in vitro. J Urol 150: 514-518
22. Hicks C, Cooley MA and Penny R (1991) Investigation of interleukin-2 receptors on human endothelial cells. Growth Factors 5: 201-208
23. Liu JH, Wei S, Ussery D, Epling-Burnette PK, Leonard WJ and Djeu JY (1994) Expression of interleukin-2 receptor gamma chain on human neutrophils. Blood 84: 3870-3875
24. Lum BL and Torti FM (1995) Immunotherapy and the prospects for immunologic-hased gene therapy in superficial bladder cancer. FORUM Trends Exp Clin Med 5: 410-439
25. Masters JRW, Hepburn PJ, Walker L, Highman WJ, Trejdosiewicz LK, Povey S, Parkar M, Hill BT, Riddle PR and Franks LM (1986) Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res 46: 3630-3636
26. Meazza R, Marciano S, Sforzini S, Orengo AM, Coppolecchia M, Musiani P, Ardizzoni A, Santi L, Azzarone B and Ferrini S (1996) Analysis of IL-2 receptor expression and of the biological effects of IL-2 gene transfection in small cell lung cancer. Br J Cancer 74: 788-795
27. Melani C, Chiodoni C, Arienti F, Maccalli C, Sule-Suso J, Anichini A, Colombo MP and Parmiani G (1994) Cytokine gene transduction in tumour cells: IL-2 or IL-4 gene transfer in human melanoma cells. Nat Immun Cell Growth Regul 13: 76-94
28. Musiani P, Modesti A, Giovarelli M, Cavallo F, Colombo MP, Lollini PL and Forni G (1997) Cytokines, tumour-cell death and immunogenicity: a question of choice. Immunol Today 18: 32-36
29. Nista A, Maltioni M, Gismondi A, Palmieri G and Santoni A (1996) β1 integrin expression and function in human bladder cancer cells: modulation by TNFα. Anticancer Res 16: 581-588
30. Okamoto M, Hattori K and Oyasu R (1997) Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro. Int J Cancer 72: 149-194
31. Pericle F, Kirken RA, Epling-Burnette PK, Blanchard DK and Djeu JY (1996) Direct killing of interleukin-2-transfected tumor cells by human neutrophils. Int J Cancer 66: 367-373
32. Sette A, Adorini L, Marubini E and Doria G (1986) A microcomputer program for probit analysis of interleukin-2 (IL-2) titration data. J Immunol Methods 75: 34-40
33. Sitkovsky MV and Paul WE (1988) Immunology. Global or directed exocytosis? Nature 332: 306-307
34. Stein U, Walther W and Shoemaker RH (1996) Reversal of multidrug resistance by transduetion of cytokine genes into human colon carcinoma cells. J Natl Cancer Inst 88: 1383-1392
35. Tubaro A, Velotti F, Stoppacciaro A, Santoni A, Vicentini C, Bossola PC, Galassi P, Pettinato A, Morrone S, Napolitano T, Frati L, Ruco L, Franks CR, Palmer PA. Pourreau CN and Miano L (1991) Continuous intra-arterial administration of recombinant interleukin-2 in low-stage bladder cancer. Cancer 68: 56-61
36. Tubaro A, Stoppacciaro A, Velotti F, Bossola PC, Cusumano G, Vicentini C, De Carli P, Ruco L, Santoni A, Cancrini A, Giuffrida AM, Cippitelli M, Palmer PA and Miano L (1995) Local immunotherapy of superficial bladder cancer by intravesical instillation of recombinant interleukin-2. Eur Urol 28: 297-303
37. Velotti F, Sloppacciaro A, Ruco L, Tubaro A, Pettinato A, Morrone S, Napolitano T, Bossola PC, Franks CR, Palmer PA, Pourreau CN, Piccoli M, Baroni CD, Fratt L, Miano L and Santoni A (1991a) Local activation of immune response in bladder cancer patients treated with intra-arterial infusion of recombinant interleukin-2. Cancer Res 51: 2456-2462
38. Velotti F, Stoppacciaro A, Tubaro A, Giuffrida A, Morrone S, Ruco L, Vicentini C, Tonelli VH, Miano L and Santoni A (1991b) Immune response in bladder cancer patients (pts) treated with two different recombinant interleukin-2 (rIL-2) local/regional regimens. Proc Am Ass Cancer Res (abstract 246)
39. Velotti F, Cippitelli M, Giuffrida AM, Punturieri A, Moretti F, Stoppacciaro A, Tubaro A, De Maria R and Santoni A (1994) Local immunotherapy of human bladder cancer with recombinant IL-2: activation of immune response and possible direct action of IL-2 on tumour cells. In Cytokine-induced Tumour Immunogenicity. From Exogenous Molecules to Gene Therapy, Forni G, Foà R, Santoni A, Frati L (eds), pp. 429-422 Academic Press: London
40. Verstovsek S, MacCubbin D, Ehrka MJ and Mihich E (1992) Tumoricidal activation of murine resident peritoneal macrophages by interleukin-2 and tumor necrosis factor α. Cancer Res 52: 3880-3885
41. Xu H, Zhou Y, Seigne J, Perng G, Mixon M, Zhang C, Li J, Benedict WF and Hu S (1996) Enhanced tumour suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein. Cancer Res 56: 2245-2249
42. Yasumura S, Lin WC, Weidmann E, Hebda P and Whiteside TL (1994) Expression of interleukin-2 receptors on human carcinoma cell lines and tumour growth inhibition by interleukin-2. Int J Cancer 59: 225-234
43. Wei S, Blanchard DK, Liu JH, Leonard WJ and Djeu JY (1993) Activation of tumor necrosis factor-alpha production from human neutrophils by IL-2 via IL-2-R beta. J Immunol 150: 1979-1987
44. Wei S, Liu JH, Blanchard DK and Djeu JY (1994) Induction of IL-8 gene expression in human polymorphonuclear neutrophils by recombinant IL-2. J Immunol 152: 3630-3636